RXRX News and Press, Recursion Pharmaceuticals Inc. From 02/23/24

2024-02-23 06:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-22 14:41:34 ET More on Amgen, Eli Lilly, etc. Pfizer's Post-Pandemic Pivot Pfizer: Turnaround Is Gaining Momentum Eli Lilly: Yes, It Is Too Late To Join The Party Novo to face Wegovy competition in India as local versions loom: Reuters Weight-...

SALT LAKE CITY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide business updates and report its fourth quarter and full year 2023 financial results on Tuesday...

2024-02-19 19:55:00 ET Summary SoundHound got a 76% share price boost on Thursday thanks to a newly disclosed investment from $1.8 trillion chipmaker Nvidia. After making 20 different investments in AI companies last year alone, more than even technology giants Alphabet and Micros...

2024-02-17 07:00:00 ET More on Nvidia and SoundHound AI Nvidia's Rally: Navigating The Surge Amidst A Tech Renaissance Nvidia: Buy Protection Before Earnings Nvidia: Strong Market Growth Enables It For 15% Annual Returns AI bets: Nvidia reports stakes in Arm ...

2024-02-15 18:27:21 ET There's nothing like a buy-in from a famous company to juice the price of a smaller stock. That was the dynamic that pushed Recursion Pharmaceuticals ' (NASDAQ: RXRX) share price nearly 14% higher on Thursday, as a regulatory filing revealed the involvement of...

2024-02-15 07:15:53 ET As the artificial intelligence (AI) industry continues to evolve, Nvidia (NASDAQ: NVDA) has positioned itself as a key player, recording solid performances and climbing the ranks in terms of company size. Following the news of Nvidia’s ownership, NNOX s...

2024-02-15 04:02:57 ET More on Nvidia Nvidia: Buy Protection Before Earnings Nvidia: Navigating The Surge Amid A Tech Renaissance Nvidia: Strong Market Growth Enables 15% Annual Returns Tudor Investment exits Airbnb, Adobe; boosts Nvidia, Splunk Nvidi...

2024-02-14 15:41:42 ET More on CRISPR, Intellia Therapeutics, etc. Intellia's Bet On In-Vivo Breakthroughs: A Perspective On CRISPR's Next Frontier Crispr Therapeutics: Investors Bet Against Casgevy Uptake Biotech And Pharma Diversification Pays Off Vertex, C...

2024-02-12 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...